Stockscreener 앱 받기
11.59
9.38%
-1.20
시간 외 거래:
11.53
-0.06
-0.52%
전일 마감가:
$12.79
열려 있는:
$12.1
하루 거래량:
1.43M
Relative Volume:
0.90
시가총액:
$545.77M
수익:
$217.11M
순이익/손실:
$-651.19M
주가수익비율:
-0.8922
EPS:
-12.99
순현금흐름:
$-387.26M
1주 성능:
-9.03%
1개월 성능:
-28.19%
6개월 성능:
+64.63%
1년 성능:
+51.90%
1일 변동 폭
$11.55
$12.45
1주일 범위
$11.55
$13.18
52주 변동 폭
$5.00
$17.58
깅코 바이오웍스 홀딩스 Stock (DNA) Company Profile
명칭
Ginkgo Bioworks Holdings Inc
전화
(877) 442-5362
주소
27 DRYDOCK AVENUE, BOSTON
DNA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
11.59 | 757.16M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
깅코 바이오웍스 홀딩스 Stock (DNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-15 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-05-10 | 다운그레이드 | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-06-02 | 다운그레이드 | Goldman | Neutral → Sell |
| 2023-05-11 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | 개시 | Berenberg | Buy |
| 2022-10-04 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-03-02 | 재개 | Cowen | Outperform |
| 2022-02-23 | 개시 | Goldman | Neutral |
| 2022-02-01 | 개시 | BofA Securities | Neutral |
| 2022-01-28 | 개시 | BofA Securities | Buy |
| 2022-01-07 | 개시 | BTIG Research | Buy |
| 2021-11-29 | 개시 | Jefferies | Buy |
| 2021-10-13 | 개시 | Raymond James | Outperform |
| 2021-10-12 | 개시 | William Blair | Outperform |
| 2021-09-20 | 개시 | HSBC Securities | Buy |
모두보기
깅코 바이오웍스 홀딩스 주식(DNA)의 최신 뉴스
Will Ginkgo Bioworks Holdings Inc. stock gain from lower inflationJuly 2025 Macro Moves & Entry and Exit Point Strategies - newser.com
Exit strategy if you’re trapped in Ginkgo Bioworks Holdings Inc.2025 Dividend Review & Entry Point Confirmation Signals - newser.com
Ginkgo Bioworks Holdings Inc. stock daily chart insightsJuly 2025 Earnings & Stepwise Swing Trade Plans - newser.com
Ginkgo Bioworks Holdings, Inc. $DNA Shares Sold by AlphaQuest LLC - MarketBeat
Is Ginkgo Bioworks Holdings Inc. stock oversold or undervaluedWeekly Stock Report & High Yield Stock Recommendations - newser.com
Is it time to cut losses on Ginkgo Bioworks Holdings Inc.Market Activity Report & Entry Point Confirmation Signals - newser.com
Ginkgo Bioworks Wins Project Agreement Through BARDA's BioMaP-Cons Consortium - MarketScreener
Real time pattern detection on Ginkgo Bioworks Holdings Inc. stockWeekly Market Report & AI Enhanced Trade Execution Alerts - newser.com
Ginkgo (NYSE: DNA) awarded $22.2M BARDA BioMaP project to cut mAb manufacturing costs - Stock Titan
Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture - MarketScreener
Will Ginkgo Bioworks Holdings Inc. continue its uptrendGap Down & Verified Stock Trade Ideas - newser.com
Can Ginkgo Bioworks Holdings Inc. stock beat market expectations this quarterWeekly Trend Report & Daily Chart Pattern Signals - newser.com
Statistical indicators supporting Ginkgo Bioworks Holdings Inc.’s strength2025 Volume Leaders & Safe Capital Growth Trade Ideas - newser.com
How interest rate cuts could boost Ginkgo Bioworks Holdings Inc. stockShare Buyback & Free Verified High Yield Trade Plans - newser.com
Can Ginkgo Bioworks Holdings Inc. Class stock resist broad market declinesJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - newser.com
Live market analysis of Ginkgo Bioworks Holdings Inc.2025 Stock Rankings & Safe Entry Trade Reports - newser.com
Visual trend scoring systems applied to Ginkgo Bioworks Holdings Inc.Portfolio Performance Report & Daily Volume Surge Trade Alerts - newser.com
Is Ginkgo Bioworks Holdings Inc. stock dividend yield sustainableQuarterly Trade Review & High Win Rate Trade Tips - newser.com
Is Ginkgo Bioworks Holdings Inc. Class stock a defensive play amid uncertaintyWeekly Trade Analysis & Low Volatility Stock Recommendations - newser.com
Ginkgo Bioworks (DNA) Expected to Announce Earnings on Thursday - MarketBeat
Why Ginkgo Bioworks Holdings Inc. Class stock fits value portfoliosSwing Trade & Safe Investment Capital Preservation Plans - newser.com
Ginkgo Bioworks Holdings, Inc. (DNA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Ginkgo Bioworks Announces Date of First Quarter 2024 Results Pre - GuruFocus
Ginkgo Bioworks (NYSE:DNA) Shares Up 9.2%Here's What Happened - MarketBeat
Using Python tools to backtest Ginkgo Bioworks Holdings Inc. strategiesInsider Selling & Low Risk High Win Rate Stock Picks - newser.com
Will Ginkgo Bioworks Holdings Inc. Class stock announce a stock split2025 Volatility Report & Safe Capital Growth Plans - newser.com
Ginkgo Bioworks stock surges after extending Bayer partnership By Investing.com - Investing.com Canada
Ginkgo Bioworks, Bayer extend partnership for agricultural biologicals By Investing.com - Investing.com Canada
Ginkgo Bioworks (NYSE: DNA) extends Bayer alliance to develop microbial nitrogen fixation - Stock Titan
How sentiment analysis helps forecast Ginkgo Bioworks Holdings Inc.July 2025 Fed Impact & Consistent Profit Focused Trading Strategies - newser.com
깅코 바이오웍스 홀딩스 (DNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):